JP2006519831A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519831A5 JP2006519831A5 JP2006506264A JP2006506264A JP2006519831A5 JP 2006519831 A5 JP2006519831 A5 JP 2006519831A5 JP 2006506264 A JP2006506264 A JP 2006506264A JP 2006506264 A JP2006506264 A JP 2006506264A JP 2006519831 A5 JP2006519831 A5 JP 2006519831A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- disorder
- disorders
- tetrazol
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CC(*)(*)C(C)(*)N Chemical compound CC(*)(*)C(C)(*)N 0.000 description 3
- MSHWTKGAZGNGGH-UHFFFAOYSA-N CC(C)C(N1)=NOC1=O Chemical compound CC(C)C(N1)=NOC1=O MSHWTKGAZGNGGH-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45287103P | 2003-03-07 | 2003-03-07 | |
| PCT/IB2004/000510 WO2004078734A1 (en) | 2003-03-07 | 2004-02-23 | TETRAZOLE AND OXADIAZOLONE SUBSTITUTED β-AMINO ACID DERIVATIVES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519831A JP2006519831A (ja) | 2006-08-31 |
| JP2006519831A5 true JP2006519831A5 (https=) | 2007-03-01 |
Family
ID=32962749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006506264A Withdrawn JP2006519831A (ja) | 2003-03-07 | 2004-02-23 | テトラゾール及びオキサジアゾロン置換β−アミノ酸誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7250433B2 (https=) |
| EP (1) | EP1603890A1 (https=) |
| JP (1) | JP2006519831A (https=) |
| BR (1) | BRPI0408110A (https=) |
| CA (1) | CA2518218A1 (https=) |
| MX (1) | MXPA05009504A (https=) |
| WO (1) | WO2004078734A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1622613A4 (en) * | 2003-05-14 | 2008-04-02 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| GB0521743D0 (en) * | 2005-10-25 | 2005-11-30 | Novartis Ag | Organic compounds |
| US9284294B2 (en) | 2012-02-09 | 2016-03-15 | Novus International, Inc. | Functionalized polymer compositions |
| PL2871973T3 (pl) | 2012-07-12 | 2019-02-28 | Novus International Inc. | Kompozycje matrycy i warstwy do ochrony środków bioaktywnych |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| US6197819B1 (en) | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| WO1999008670A1 (en) | 1997-08-20 | 1999-02-25 | Guglietta, Antonio | Gaba analogs to prevent and treat gastrointestinal damage |
| US6518289B1 (en) * | 1997-12-16 | 2003-02-11 | Pfizer, Inc. | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| NZ503980A (en) * | 1997-12-16 | 2002-09-27 | Warner Lambert Co | 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (= gabapentin analogues), pharmaceuticals thereof, and their use in the treatment of neurological disorders |
| DK1045839T3 (da) * | 1997-12-16 | 2004-07-05 | Warner Lambert Co | Hidtil ukendte aminer som farmaceutiske midler |
| EP1082306A1 (en) | 1998-05-26 | 2001-03-14 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| WO2000015611A1 (en) | 1998-09-14 | 2000-03-23 | Warner-Lambert Company | Branched alkyl pyrrolidine-3-carboxylic acids |
| CN1625393A (zh) | 2002-01-31 | 2005-06-08 | 沃纳-兰伯特公司 | 治疗耳鸣的α2δ配体 |
-
2004
- 2004-02-23 BR BRPI0408110-2A patent/BRPI0408110A/pt not_active IP Right Cessation
- 2004-02-23 JP JP2006506264A patent/JP2006519831A/ja not_active Withdrawn
- 2004-02-23 MX MXPA05009504A patent/MXPA05009504A/es unknown
- 2004-02-23 WO PCT/IB2004/000510 patent/WO2004078734A1/en not_active Ceased
- 2004-02-23 CA CA002518218A patent/CA2518218A1/en not_active Abandoned
- 2004-02-23 EP EP04713604A patent/EP1603890A1/en not_active Withdrawn
- 2004-03-08 US US10/795,760 patent/US7250433B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9469645B2 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| JP5860417B2 (ja) | カテコールｏ−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用 | |
| CN102164604A (zh) | 用作激酶调节剂的稠合杂环化合物 | |
| WO2005040135A1 (ja) | 抗ストレス薬およびその医薬用途 | |
| JP2010536752A5 (https=) | ||
| JPWO2005047286A1 (ja) | スピロ複素環化合物 | |
| RS56807B1 (sr) | Jedinjenja aminopirimidinila kao jak inhibitori | |
| WO2014058071A1 (ja) | シクロプロパンアミン化合物およびその用途 | |
| JP2012518038A5 (https=) | ||
| JP2014500332A (ja) | Ｆａａｈ阻害剤 | |
| US8618300B2 (en) | Indolizine inhibitors of leukotriene production | |
| JP6592512B2 (ja) | 三環式アトロプ異性体の化合物 | |
| US12195432B2 (en) | 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases | |
| JP6250674B2 (ja) | Ｎ型カルシウムチャネル遮断剤としてのピロロピラゾール | |
| TW200534850A (en) | Hydroisoindoline tachykinin receptor antagonists | |
| JP2011518866A (ja) | ５−（２−アミノ−ピリミジン−４−イル）−２−アリール−ｌＨ−ピロール−３−カルボキサミドの製造方法 | |
| JP2000501411A (ja) | ベンゾフランカルボキサミドおよびスルホンアミド | |
| JP2024160326A (ja) | Ｅａａｔ２活性化因子およびその使用方法 | |
| TW200835686A (en) | Novel compounds 621 | |
| EP4688748A1 (en) | Quinolinone amide compounds and uses thereof | |
| TW200423937A (en) | Quinazoline compounds | |
| JP2020510007A (ja) | オピオイド受容体調節因子としての多環式アミン | |
| US20130109721A1 (en) | FAAH Inhibitors | |
| EP4688756A1 (en) | Quinazoline dione compounds and uses thereof | |
| JPWO2008050732A1 (ja) | イミノピリジン誘導体およびその用途 |